Theory Practice Seminar: Advancing AI in Medicine
The Role of Law and Policy in Accelerating Medical Research
About the Seminar
There are two AI dreams in medicine. The first is utopian, straight out of science fiction novels. Care robots will spot and treat any disease, instantly. Nano-bots will patrol our veins and arteries, breaking up incipient blockages and repairing damaged tissues. Three-dimensional printed organs, bone, and skin will keep us all looking and feeling young well into our 80s and 90s. With enough luck, even brains can be uploaded for perpetual safekeeping, with robotic bodies sleeving indestructible minds.
Whatever its long-term merits, that sci-fi vision is far, far off—if it ever arrives at all. More realistic medical futurists are still ambitious but offer more realizable visions. They recognize the critical role that human empathy plays in care, that human insight contributes to diagnose, and that human dexterity adds to surgery. But even these realists tend to stumble when it comes to policy and law. They see health care systems through a primarily economic lens, lamenting their expense. They want deregulation and market-driven competition to cut costs and to spur innovation. However, what we really need in medical robotics is more responsibility and opportunity to collect and use better data. And we need to invest in the cutting edge of medical practice, rather than simply assuming that hospitals and doctors will come up with ever more ingenious ways of “doing more with less.” This talk will explore how reimbursement and data policy can accelerate the development of medical AI.
Sponsored by the Center for Health, Science & Public Policy
Panelists
Frank Pasquale, Piper & Marbury Professor of Law, University of Maryland Francis King Carey School of Law; Visiting Professor of Law, Brooklyn Law School
Anthony B. Costa, PhD, Assistant Professor, Department of Neurosurgery; COO of the Mount Sinai AI Consortium (AISINAI), Mount Sinai Health System; Director, Sinai BioDesign, Icahn School of Medicine at Mount Sinai
Eric Karl Oermann, MD, Instructor, Department of Neurosurgery; Director of AISINAI, Mount Sinai Health System
About the Seminar
There are two AI dreams in medicine. The first is utopian, straight out of science fiction novels. Care robots will spot and treat any disease, instantly. Nano-bots will patrol our veins and arteries, breaking up incipient blockages and repairing damaged tissues. Three-dimensional printed organs, bone, and skin will keep us all looking and feeling young well into our 80s and 90s. With enough luck, even brains can be uploaded for perpetual safekeeping, with robotic bodies sleeving indestructible minds.
Whatever its long-term merits, that sci-fi vision is far, far off—if it ever arrives at all. More realistic medical futurists are still ambitious but offer more realizable visions. They recognize the critical role that human empathy plays in care, that human insight contributes to diagnose, and that human dexterity adds to surgery. But even these realists tend to stumble when it comes to policy and law. They see health care systems through a primarily economic lens, lamenting their expense. They want deregulation and market-driven competition to cut costs and to spur innovation. However, what we really need in medical robotics is more responsibility and opportunity to collect and use better data. And we need to invest in the cutting edge of medical practice, rather than simply assuming that hospitals and doctors will come up with ever more ingenious ways of “doing more with less.” This talk will explore how reimbursement and data policy can accelerate the development of medical AI.
Sponsored by the Center for Health, Science & Public Policy
Panelists
Frank Pasquale, Piper & Marbury Professor of Law, University of Maryland Francis King Carey School of Law; Visiting Professor of Law, Brooklyn Law School
Anthony B. Costa, PhD, Assistant Professor, Department of Neurosurgery; COO of the Mount Sinai AI Consortium (AISINAI), Mount Sinai Health System; Director, Sinai BioDesign, Icahn School of Medicine at Mount Sinai
Eric Karl Oermann, MD, Instructor, Department of Neurosurgery; Director of AISINAI, Mount Sinai Health System